Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
eNews November 2010 - National MS Society
Symptom affects 1 in 10 people with MS

Nuedexta approved for pseudobulbar affect

The first drug specifically developed to treat uncontrollable laughing or crying, or pseudobulbar affect, was approved by the U.S. Food and Drug Administration on October 29. Clinical trials showed that Nuedexta, which is taken orally, significantly reduced episodes in people with MS, ALS and other disorders.

Read more


 Find us on Facebook 

YouTube MySpace Twitter



Tom Holtackers

Tom Holtackers, 2010 Volunteer of the Year


 2010 Volunteer Honorees

All of our 2010 Volunteer Honorees


Nearly 1,000 MS studies shared at global conference Nearly 1,000 MS studies shared at global conference

Researchers convened in Sweden last month at the annual ECTRIMS (European Committee for Treatment and Research in MS) conference. Results were presented on emerging MS therapies, including Teriflunomide, an oral drug that inhibits specific immune cells. In addition, two presentations and 14 posters reported on ongoing CCSVI research.

Read more

November is Caregiver Month November is Caregiver Month

This month marks the 10th anniversary of the National Family Caregiver Support program. The Society’s MS and Carepartners page includes a wealth of information and resources as well as tools and materials to help honor caregivers.

Get info

Celebrate caregivers

Unstoppable! Join the Society’s National ConferenceUnstoppable! Join the Society’s National Conference
Meet people moving their lives forward with MS, get inspired by some of our volunteer leaders and more at the National MS Society’s National Conference. Streaming video of event highlights is now archived so everyone can join the movement.

Join the Movement® now

More MS News 
Nov 2: Society partners with MSFriends to provide 24/7 telephone support to people living with MS

Oct 29: Investigators recruiting for study of effects of low-fat diet on MS disease activity; travel costs covered

Read more about these and other recent reports

This communication is partially sponsored through the generous support of Bayer HealthCare, Biogen Idec, Novartis Pharmaceuticals Corporation, and Teva Neuroscience, Inc.


eNews Bayer HealthCare       MS Active Source         Novartis Pharmaceuticals       Teva Neuroscience  

Shop at the Society Store       Join a Walk MS Event       Join a Bike MS Event

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our Web site.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to . To ensure that you continue to receive our emails, please add us to your address book.